دورية أكاديمية

Outcomes of emergent cardiac surgery after transcatheter aortic valve implantation.

التفاصيل البيبلوغرافية
العنوان: Outcomes of emergent cardiac surgery after transcatheter aortic valve implantation.
المؤلفون: van Steenbergen, Gijs J., Olsthoorn, Jules R., Eerdekens, Rob, Tan, Erwin, Tonino, Pim A. L., Lam, Ka Yan
المصدر: Netherlands Heart Journal; Dec2023, Vol. 31 Issue 12, p479-488, 10p
مصطلحات موضوعية: CARDIAC surgery, HEART valve prosthesis implantation, CARDIAC pacemakers, AORTIC valve transplantation, SURGICAL site
مصطلحات جغرافية: NETHERLANDS
مستخلص: Objective: The aim of this study was to evaluate the reasons for emergent cardiac surgery (ECS) after transcatheter aortic valve implantation (TAVI) and assess outcomes of these patients. Methods: All patients undergoing ECS following a complicated TAVI procedure at a high-volume TAVI centre in the Netherlands from 1 January 2008 to 1 April 2022 were included. Baseline and procedural characteristics and outcome data (procedural, 30-day and 1‑year mortality, in-hospital stroke, 30-day pacemaker implantation, 30-day vascular complications, 30-day deep sternal wound infections and 30-day re-exploration) were collected from patient files and analysed using descriptive statistics. Results: During the study period, 16 of 1594 patients (1.0%) undergoing TAVI required ECS. The main reason for ECS was valve embolisation (n = 9; 56.3%), followed by perforation of the left/right ventricle with guide wire/pacemaker lead (n = 3; 18.8%) and annular rupture (n = 3; 18.8%). Procedural, 30-day and 1‑year mortality was 0%, 18.8% (n = 3) and 31.3% (n = 5), respectively. In-hospital stroke occurred in 1 patient (6.3%), a pacemaker was implanted at 30 days in 2 patients (12.5%), and major vascular complications did not occur. Conclusion: ECS following complicated TAVI was performed in only a small number of cases. It had a high but acceptable perioperative and 30-day mortality, taking into account the otherwise lethal consequences. In case of valve embolisation, no periprocedural or 30-day mortality was observed for surgical aortic valve replacement (even in a redo setting), which supported the necessity to perform TAVI in centres with cardiac surgical backup on site. [ABSTRACT FROM AUTHOR]
Copyright of Netherlands Heart Journal is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:15685888
DOI:10.1007/s12471-023-01820-0